Used for the acute treatment of migraine with or without aura in adults. It acts selectively on serotonin 5-HT1F receptors in the central nervous system, helping to reduce migraine symptoms without causing vasoconstriction, making it suitable for patients with cardiovascular concerns. Lasmiditan succinate crosses the blood-brain barrier and is effective in relieving pain, photophobia, and phonophobia during migraine attacks. Due to its sedative effects, patients are advised not to drive or operate machinery after taking the medication.